A Phase I Clinical Study of BBI608 in Adult Patients With Advanced Malignancies

Trial Profile

A Phase I Clinical Study of BBI608 in Adult Patients With Advanced Malignancies

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 19 Oct 2015

At a glance

  • Drugs Napabucasin (Primary)
  • Indications Colorectal cancer; Multiple myeloma; Solid tumours
  • Focus Adverse reactions
  • Sponsors Boston Biomedical
  • Most Recent Events

    • 13 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 17 Jul 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov
    • 02 Jun 2015 Planned End Date changed from 1 Jun 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top